The results of research on the antioxidant emoksipin in clinical eye diseases
Egorov, E.A.; Shvedova, A.A.; Obraztsova, I.A.
Vestnik Oftalmologii 105(5): 52-55
1989
ISSN/ISBN: 0042-465X PMID: 2595902 Document Number: 4751
Emoxipin, a new lipid peroxidation inhibitor, has been used in the treatment of various ophthalmic diseases. The drug is characterized by a retinal-protective and an additional fibrinolytic effects; it has been effectively used to preserve the visual function in glaucoma, to treat intraocular hemorrhages and retinal injuries with physical, chemical, or bacterial factors. A manifest effect has been observed in 87% of 106 patients (118 eyes) with various ocular abnormalities. Emoxipin is recommended for the treatment of a variety of ocular diseases.
Document emailed within 1 workday